287 related articles for article (PubMed ID: 1712326)
1. Targeted therapy of human immunodeficiency virus-related disease.
Mitsuya H; Yarchoan R; Kageyama S; Broder S
FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
[TBL] [Abstract][Full Text] [Related]
2. NIH conference. Antiretroviral therapy in AIDS.
Broder S; Mitsuya H; Yarchoan R; Pavlakis GN
Ann Intern Med; 1990 Oct; 113(8):604-18. PubMed ID: 1698042
[TBL] [Abstract][Full Text] [Related]
3. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets for AIDS therapy.
Mitsuya H; Yarchoan R; Broder S
Science; 1990 Sep; 249(4976):1533-44. PubMed ID: 1699273
[TBL] [Abstract][Full Text] [Related]
5. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
Gu Z; Gao Q; Li X; Parniak MA; Wainberg MA
J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
[TBL] [Abstract][Full Text] [Related]
7. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
Shirasaka T; Yarchoan R; O'Brien MC; Husson RN; Anderson BD; Kojima E; Shimada T; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):562-6. PubMed ID: 8380641
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Balzarini J
Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.
Kamali F
Clin Investig; 1993 May; 71(5):392-405. PubMed ID: 7685214
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
12. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
13. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
14. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
Whitfield RM; Bechtel LM; Starich GH
Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
[TBL] [Abstract][Full Text] [Related]
15. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
St Clair MH; Martin JL; Tudor-Williams G; Bach MC; Vavro CL; King DM; Kellam P; Kemp SD; Larder BA
Science; 1991 Sep; 253(5027):1557-9. PubMed ID: 1716788
[TBL] [Abstract][Full Text] [Related]
16. Treatment of AIDS with combinations of antiretroviral agents.
Merigan TC
Am J Med; 1991 Apr; 90(4A):8S-17S. PubMed ID: 1850192
[TBL] [Abstract][Full Text] [Related]
17. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
Perno CF; Cooney DA; Gao WY; Hao Z; Johns DG; Foli A; Hartman NR; Caliò R; Broder S; Yarchoan R
Blood; 1992 Aug; 80(4):995-1003. PubMed ID: 1379854
[TBL] [Abstract][Full Text] [Related]
18. Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides.
Pizzo PA
Am J Med; 1990 May; 88(5B):16S-19S. PubMed ID: 2159704
[TBL] [Abstract][Full Text] [Related]
19. Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages.
Perno CF; Yarchoan R; Balzarini J; Bergamini A; Milanese G; Pauwels R; De Clercq E; Rocchi G; Calio R
Antiviral Res; 1992 Apr; 17(4):289-304. PubMed ID: 1322645
[TBL] [Abstract][Full Text] [Related]
20. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
